Cargando…
Interleukin-37 Mediates the Antitumor Activity in Hepatocellular Carcinoma: Role for CD57+ NK Cells
The biological role of interleukin-37 (IL-37) in cancer is large unknown. Through immunohistochemical detection using 163 primary hepatocellular carcinoma (HCC) clinical specimens, we found the expression of IL-37 was decreased in tumor tissues, and the expression level was negatively correlated wit...
Autores principales: | Zhao, Jing-Jing, Pan, Qiu-Zhong, Pan, Ke, Weng, De-Sheng, Wang, Qi-Jing, Li, Jian-Jun, Lv, Lin, Wang, Dan-Dan, Zheng, Hai-Xia, Jiang, Shan-Shan, Zhang, Xiao-Fei, Xia, Jian-Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046124/ https://www.ncbi.nlm.nih.gov/pubmed/24898887 http://dx.doi.org/10.1038/srep05177 |
Ejemplares similares
-
Identification of LZAP as a New Candidate Tumor Suppressor in Hepatocellular Carcinoma
por: Zhao, Jing-jing, et al.
Publicado: (2011) -
IL-37 induces anti-tumor immunity by indirectly promoting dendritic cell recruitment and activation in hepatocellular carcinoma
por: Liu, Yuan, et al.
Publicado: (2019) -
Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
por: Jiang, Shan-Shan, et al.
Publicado: (2014) -
Overexpression of WWP1 Promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma
por: Zhang, Xiao-Fei, et al.
Publicado: (2015) -
TES functions as a Mena-dependent tumor suppressor in gastric cancer carcinogenesis and metastasis
por: Wang, Dan-dan, et al.
Publicado: (2019)